North America

Warning message

The subscription service is currently unavailable. Please try again later.
Mon
04
Jul

Is Aurora Cannabis too cheap to pass up right now?

chart

 

Some analysts have become more optimistic about the stock.

Aurora Cannabis (ACB -5.10%) is one of the most beaten-down cannabis stocks in the entire industry. Investors will recall that back in 2018, Aurora announced it was acquiring medical marijuana company MedReleaf for more than $2.5 billion in what at the time was the sector's largest deal. Today, Aurora is worth about one-fifth of that value, with a market cap of over $400 million.

Thu
30
Jun

Ask Dr. Leigh: Will medical marijuana help my autistic child, or hurt them?

mom and child

Using cannabis can have a big impact on your physical and mental health—for better, and sometimes for worse. That’s why it’s important to consult a healthcare provider before experimenting.

Here at GreenState, cannabis clinician Dr. Leigh Vinocur is here to answer your questions on healthy living with cannabis.

Editor’s Note: The answer to this question is meant to supplement, not replace, advice, diagnoses, and treatment from a healthcare provider.  Always consult a medical professional when using cannabis for medicinal purposes, and do not disregard the advice of your healthcare provider because of anything you may read in this article. 

Thu
30
Jun

Getting high during a heat wave: How to safely use cannabis during summer

woman

Some precautions and tips for smoking or sipping in soaring temps.

Record heat events are starting to become the norm these days. Much of the US has already experienced multiple heat waves, and summer has only just begun. When the weather gets oppressively hot, there is not much you can do to improve the situation other than to stay hydrated, and if you consume cannabis, maybe get high and hope for a breeze.

Thu
30
Jun

Bio-Sunn Technologies Inc. signs LOI to provide GCAC supply chain software to the hemp industry

logo

lobal Cannabis Applications Corp. ("GCAC" or the "Company") (CSE:APP), (FSE:2FA), (OTC:FUAPF), a leading blockchain driven compliance and data platform announce that Bio-Sunn Technologies Inc.  (“Bio-Sunn”) and GCAC have entered into a Letter of Intent  (“LOI”) that enables processor Bio-Sunn to work with industrial and CBD hemp growers to develop premium products on a sustainable and transparent supply chain using the Company’s “Efixii” and “clearESG” software. The Definitive Agreement is to be signed no later than July 31, 2022.

Wed
29
Jun

JourneyOne harvests a dope $10M fund to invest in cannabis tech

woman

 

As the cannabis markets are maturing, we’re seeing new opportunities rise to the surface. JourneyOne Ventures told TechCrunch it’s closed a $10 million fund and has started making its first investments. I spoke with the fund’s solo manager, Helene Servillon, to figure out where the opportunities are in this market.

“There’s only a specific amount of time that I have, until Andreessen Horowitz, First Round Capital and Sequoia Capital are starting to play in this industry. Right now, I don’t have to compete with them, so I want to use that as my advantage,” Servillon told me in an interview, noting that there are other big players in this space, especially on the corporate side of things.

Wed
29
Jun

Research finds weekly use of marijuana doesn’t compromise physical health

woman

With dozens of states passing some form of cannabis legislation in the past decade, more people than ever are using marijuana for either medical or recreational purposes. According to recent research, regular cannabis use has a minimal effect on a user’s physical health. The study adds to the growing body of research on how marijuana affects pulmonary, cardiovascular and other biological functions. Since federal law has made it virtually impossible for researchers to study cannabis for the past few decades, most of the research on the effects of regular cannabis use is quite new. This recent study, whose findings were reported in the Drug and Alcohol Dependence journal, sought to investigate the effect of regular (once a week) cannabis use on physical health.

Tue
28
Jun

Recession to wipe out weed firms trying to make ‘quick buck’

graph

With investors becoming more cautious and capital more expensive, only the strongest cannabis firms will survive a downturn in the global economy. 

Cannabis startups in Europe are facing a harder time raising capital amid recession fears and sinking stock markets, but that could ultimately help the industry. 

“This period will be really good for clearing out those who were just trying to make a quick buck,” said Alastair Moore, the founder of Hanway Associates, a research firm focused on marijuana. “That’s a good thing for the sector.”

Startups likely to survive include those that have already built strong, sustainable business models, according to Moore. That will help them keep winning over investors who are becoming more cautious, he said.

Tue
28
Jun

UN report dramatizes uptick in global cannabis use

UN logo

In their latest report on the topic, the UN equates cocaine and heroin with cannabis use and creates boogeymen around every corner of the end of Prohibition.

The UN has just issued a report about cannabis that will no doubt in the near future look as alarmist as it is dated. Namely, the UN Office on Drugs and Crime (UNODC) has issued its annual world drug report.

Here are the high level takeaways—which are hard to read with a straight face.

Tue
28
Jun

Teens are getting sick from high THC marijuana products

girl in bedroom

A new article claims higher levels of THC are affecting the health of teens.

Marijuana products can have THC levels of up to 100%. This is a relatively new development, with marijuana growers and handlers learning how to cultivate stronger products in recent years. According to The New York Times, these high levels of THC are affecting teens, increasing their odds of dependency and even resulting in conditions like cannabinoid hyperemesis syndrome.

Teen Marijuana Use Drops Dramatically In This State

Tue
28
Jun

5 surprising side effects of CBDA after age 40, expert says

woman in water

It helps with arthritis and overall inflammation.

Once you hit 40 years of age and over, your body can throw all kinds of curveballs at you. Some individuals already have or may start to develop health ailments at this stage of life, including chronic back pain, diabetes, cardiovascular issues, and more. A healthcare professional will address your particular situation and decide the best course of treatment for you. But did you know there are also surprising side effects of taking CBDA after 40?

Pages

Subscribe to RSS - North America